India's Economy Shows Resilience Amid Global Uncertainty, Driven by Strong Domestic Demand and Services Exports

India's Economy Shows Resilience Amid Global Uncertainty, Driven by Strong Domestic Demand and Services Exports


Indias economy continues to demonstrate resilience despite rising global uncertainty arising from the West Asia conflict and disruptions across energy and logistics channels. Prior to escalated geopolitical tensions, economic activity was robust through the first two months of CY 2026, supported by broad-based strength across both supply and demand indicators.

The Purchasing Managers Index (PMI) for manufacturing rose to a four-month high of 56.9 in February 2026 while the services PMI stood at 58.1. This indicates sustained expansion across both sectors. Industrial activity was supported by strong performance in domestic demand-driven segments such as steel and cement, with steel production growing by 7.2% and cement output by 9.3% in February 2026. This reflects continued infrastructure momentum and public capital expenditure support.

 

Considering the demand side, retail automobile sales expanded by 25.2% YoY in February 2026, with strong growth across two-wheelers, commercial vehicles and tractors, while digital payments volume increased by 26.6%, indicating resilient consumption demand. Indias growth momentum remains broad-based, although external shocks pose near-term downside risks due to the support of sustained capital expenditure, the Bharat Audyogik Vikas Yojna (BHAVYA) and strong domestic demand conditions.

Indias external sector remains supported by resilient services exports, strong foreign exchange reserves, and diversified trade linkages, even as rising crude oil prices and West Asia disruptions increase near-term risks. During AprilFebruary FY26, total exports of goods and services grew by 5.8% YoY to 790.9 billion USD. Merchandise exports grew modestly by 1.8% while non-petroleum, non-gems and jewellery exports increased by 5.7%, led by strong growth in electronic goods exports. Services exports remained the key strength of the external sector, rising by 10.2% to 387.9 billion USD and generating a net services surplus of 201 billion USD, covering 64.7% of the merchandise trade deficit. Total imports rose by 7.4% to 900.5 billion USD, resulting in a total trade deficit of 109.7 billion USD. Indias foreign exchange reserves remained comfortable at 709.8 billion USD as of 13 March 2026, providing over 11 months of import cover and covering around 95% of external debt outstanding, strengthening resilience against global volatility.

Powered by Capital Market – Live News



Source link

India's Economy Shows Resilience Amid Global Uncertainty, Driven by Strong Domestic Demand and Services Exports

Borosil Renewables climbs after govt levies CVD on Malaysian solar glass imports


Borosil Renewables rallied 8.84% to Rs 545.80 after the the Government imposed a countervailing duty (CVD) on Textured Toughened (Tempered) Glass made or exported from Malaysia for a period of five years.

The notified product includes textured toughened glass with a minimum of 90.5% transmission, thickness not exceeding 4.2 mm, and where at least one dimension exceeds 1500 mm (whether coated or uncoated). The product is commonly referred as solar glass, solar PV glass, or high-transmission photovoltaic glass.

Under the notification, the duty will be levied as a percentage of the CIF (Cost, Insurance and Freight) value of the imported goods. Imports from Xinyi Solar (Malaysia) Sdn. Bhd. and SBH Kibing Solar New Materials (M) Sdn. Bhd. will attract a duty of 9.71%, while imports from all other producers will be subject to a duty of 10.14%.

 

This measure will not only protect domestic manufacturers but also accelerate investments in expansion of local production, driving exponential growth across Indias solar glass industry.

Borosil Renewables is engaged in the business of manufacturing of extra clear patterned glass and low iron solar glass for application in photovoltaic panels, flat plate collectors and green houses.

The company reported consolidated net profit of Rs 169.13 crore in Q4 FY26 compared with net loss of Rs 200.99 crore in Q4 FY25.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Jun 03 2026 | 3:50 PM IST



Source link

India's Economy Shows Resilience Amid Global Uncertainty, Driven by Strong Domestic Demand and Services Exports

Lupin and alliance partner Natco receive USFDA approval for Eribulin Mesylate Injection


Lupin and its alliance partner Natco Pharma (Natco) today announced the approval from the United States Food and Drug Administration (U.S. FDA) for Natco’s Abbreviated New Drug Application (ANDA) for Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials.

Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose Vials is the bioequivalent to the reference listed drug (RLD) Halaven Injection of Eisai, Inc.

Eribulin Mesylate Injection is indicated for the treatment of adults with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease and unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen.

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Jun 03 2026 | 2:31 PM IST



Source link

Ashok Leyland skids 5%, hits 6-month low; why CV stock under pressure?

Ashok Leyland skids 5%, hits 6-month low; why CV stock under pressure?



Ashok Leyland share price

 


Share price of Ashok Leyland hit a six-month low of ₹142.25, plunging 5 per cent on the BSE in Wednesday’s intra-day trade amid heavy volumes on growth and margin concerns.

 


The stock price of the commercial vehicle (CV) company was quoting at its lowest level since November 12, 2025. It has corrected 34 per cent from its 52-week high of ₹215.35 touched on February 11, 2026.

 

At 12:03 PM; Ashok Leyland was trading 4 per cent lower at ₹143.05, as compared to 0.75 per cent decline in the BSE Sensex. A combined 22.71 million shares changed hands on the NSE and BSE. 
Check – TOP GAINERS NSE | TOP LOSERS NSE 

 


Why is Ashok Leyland stock price under pressure?

 


In the past four trading days, the market price of Ashok Leyland slipped 13 per cent after the company reported muted sales volumes with a decline of 4 per cent year-on-year (YoY) at 14,923 units in the month of May 2026.

 


Ashok Leyland is the second largest player in the domestic medium and heavy commercial vehicle truck (M&HCV) market, with a market share of 30 per cent (excluding defence) in FY26. Its light commercial vehicle (LCV) sales improved to 12.3 per cent in FY2026 (vis-à-vis around 9 per cent in FY2019) aided by increased product launches and market penetration.

 


Around 90 per cent of Ashok Leyland’s (consolidated excluding NBFC business) revenues were derived from its standalone operations. CV sales, which constituted around 85 per cent of Ashok Leyland’s standalone revenues in FY25, remains inherently cyclical in nature, with industry volumes strongly correlated to the level of economic activity, industrial growth and infrastructure investments.

 


ICRA expects a modest growth of 4-6 per cent for the CV industry in FY27. Other factors like regulatory changes (emission norms, scrappage policy, etc.) and stiff competition, and sharp fluctuation in raw material prices also impact the earnings profile of industry players. Nevertheless, improving presence in the LCV segment and higher revenues from the non-CV businesses (CAGR of around 12 per cent over the last 6 years), wherein the troughs are flatter, are likely to mitigate the cyclicality risk to an extent, the rating agency said in its rationale.

 

However, the cost-optimisation measures undertaken over the last few years, better price realisation, favourable product mix (including healthy growth in non-CV business) and benefits from operating leverage have cumulatively translated into a steady improvement in margins as well in the last few years. The measures undertaken by the company at strengthening its product portfolio (including that in the non-CV business), market position and reducing break-even levels, would support the company’s earnings going forward, ICRA said. 
CHECK Stock Market LIVE Updates 


Brokerages view on Ashok Leyland

 


Management indicated that domestic demand remained healthy in April 2022 and May 2026 despite concerns around diesel availability/prices and geopolitical uncertainties, supported by GST rationalisation, ageing fleet replacement, and fleet expansion demand. On exports, demand across GCC, Africa, and SAARC markets remains stable, though international logistics disruptions could weigh on near term exports.

 


Analysts at JM Financial Institutional Securities have factor in volume growth of 6 per cent/7.8 per cent for FY27E/FY28E. On margins, despite additional price hikes of 1–1.5 per cent effective April 2026, the brokerage firm expects near-term profitability to remain under pressure due to raw material cost inflation and denominator impact, partially offset by improving non-truck mix and ongoing cost-saving measures.

 


Choice Institutional Equities believe Ashok Leyland remain well positioned for sustained earning growth, supported by strong replacement demand, richer product mix, robust defence pipeline and improving EV traction. However, commodity inflation, diesel price volatility and logistics disruptions could weigh on near-term volumes and margin, the brokerage firm said.  ================================================  Disclaimer: View and outlook shared on the stock belong to the respective brokerages and are not endorsed by Business Standard. Readers discretion is advised. 

     



Source link

India's Economy Shows Resilience Amid Global Uncertainty, Driven by Strong Domestic Demand and Services Exports

Zydus receives warning letter from USFDA for its Baddi site


Zydus Lifesciences has received a Warning Letter from the United States Food and Drug Administration (USFDA) relating to its formula on manufacturing facility located at Baddi, Himachal Pradesh.

The Warning Letter was issued in response to a request for records pursuant to sec on 704(a)(4) of the Federal Food, Drug, and Cosmetic Act, and does not pertain to any onsite inspection of the facility by the USFDA. The communication references technical observations regarding the use of purified talc that did not meet the current United
States Pharmacopeia (USP) requirements.

The company added that the said Warning Letter will not impact current operations and supplies from the Baddi site.

 

The Baddi manufacturing facility was last subjected to an on-site inspection by the USFDA in August 2025. Subsequent to the conclusion of the inspec on, the Company received the Establishment Inspection Report (EIR) in October 2025, with the final compliance status classified as Voluntary Ac on Indicated (VAI).

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Jun 03 2026 | 12:32 PM IST



Source link

YouTube
Instagram
WhatsApp